Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

CVR Medical Corp V.CVM.H

Alternate Symbol(s):  CRRVF

CVR Medical Corp. is a medical technology organization. The Company is focused on the development and advancement of technology at work within the healthcare sector. The Company’s Carotid Stenotic Scan (CSS) is a diagnostic tool designed to detect and determine a level of carotid narrowing for the purpose of identifying patients at risk for Ischemic Stroke. The CSS provides a synergistic tool, which complements other stroke screening technology such as Duplex Doppler ultrasound (DUS), magnetic resonance angiography (MRA) and computed tomography angiography (CTA). The CSS is non-invasive and does not require the use of harmful dyes. It offers its product to patients, payers, and healthcare providers.


TSXV:CVM.H - Post by User

Bullboard Posts
Post by gamer007on Mar 17, 2020 4:57pm
201 Views
Post# 30818897

Paradigm shift is necessary !

Paradigm shift is necessary !
I have had an opportunity to think about the last release and have been able to contact our new president................an encouraging conversation ensued !!!!

What has been brought to my attention is the fact that the new board is FULLY aware of the issues plaguing our demise and are cognisant of the fact that there is a very angry culture amongst the shareholders.

They are trying to put everything under one umbrella, so the project can leave all the conflict of interest and finger pointing baggage of the past behind and move forward with a constructive focus. They have all come to the same conclusions as many here on this board.

Replacing shares for the 7 % royalty to Global..............levels the playing field...........global will be a shareholder just like anyone else and reap bottom line rewards and not skim off the top with a royalty. Whether this is fair or not is difficult to determine, and since there is so much animosity, decided to get an independent evaluation...........this I believe is very objective of them. I think it is in our favour, as we don't quite know the price point at which the market will be accepting the device in any concrete way at this point............so to give up a 7 % right off the top, would have been be a great benefit for Global............this will not occur !!

They are also bringing in more medical device talent as shown in the previous release and looking at adding more directors when appropriate............

We have taken enough pain from delays and will be taking on more dilution as well...........but in the big picture...............if this turns out to be only a 5 dollar stock in 2 or 3 years, instead of 10 dollars..............I can live with this !

This looks to me like a decisive turning point, by a new team, that will be working for the benefit of all shareholders, all interests aligned...............this is easy to swallow...........

I am suggesting we bury the anger and give them a shot...............let them show us what they can achieve............so far I like where they are going..........we all should welcome this shift !

The process has had many flaws and seemed rather hopeless at times............but I for one do see some light at the end of this tunnel...............I hope you all do as well !!

Bullboard Posts